Inflammation in atherosclerosis
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Abundant data link hypercholesterolaemia to atherogenesis. However, only recently have we appreciated that inflammatory mechanisms couple dyslipidaemia to atheroma formation. Leukocyte recruitment and expression of pro-inflammatory cytokines characterize early atherogenesis, and malfunction of inflammatory mediators mutes atheroma formation in mice. Moreover, inflammatory pathways promote thrombosis, a late and dreaded complication of atherosclerosis responsible for myocardial infarctions and most strokes. The new appreciation of the role of inflammation in atherosclerosis provides a mechanistic framework for understanding the clinical benefits of lipid-lowering therapies. Identifying the triggers for inflammation and unravelling the details of inflammatory pathways may eventually furnish new therapeutic targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The increased production of ROS and the activation of redox-dependent signaling cascades are involved in atherosclerosis (46, 78).”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [78]
In the citing paper
“Oxidative stress and increased inflammatory cytokines have been recognized as important contributing factors for several chronic diseases attributed to aging, such as atherosclerosis and related cardiovascular disorders, mutagenesis and cancer, neurodegenerative disorders, type 2 diabetes mellitus, and Alzheimer's disease (AD).”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [78]
In the citing paper
“NF-κB is one of the major immune response transcription factors involved in the initiation and development of atherosclerosis (46, 78).”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [78]
In the citing paper
“Atherosclerosis is a slowly progressive chronic inflammatory disease characterized by focal arterial lesions that ultimately block the blood vessels, which leads to angina, myocardial infarction, cerebrovascular ischemia and stroke, and even death (46, 78).”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [78]
In the citing paper
“Insulin signaling interference by adipokines leads to insulin resistance, as demonstrated by serine phosphorylation of insulin receptor substrate by TNF-α (75, 78).”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [78]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Self-citationDahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“jpg" NDATA ITEM> ]> Cardiovascular disease, currently the leading cause of death and illness in developed countries, will soon become the pre-eminent health problem worldwid”
BackgroundGalis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Self-citationMolecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,028
Self-citationBoring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965 · cited 1×
“Recent work using compound mutant mice lacking MCP-1 or its receptor CCR2, and susceptible to atherosclerosis owing to the absence of genes encoding apoE or the low-density lipoprotein (LDL) receptor, has shown striking decreases in mononuclear phagocyte accumulation and local lipid level”
BackgroundDe Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Self-citationEndothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,712
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Self-citation
Cited by
Items 701–800 of 1,105
Nieuwdorp, M., Meuwese, M. C., Mooij, H. L., van Lieshout, M. H. P., Hayden, A., Levi, M., Meijers, J. C. M., Ince, C., Kastelein, J. J. P., Vink, H., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.03.024 · Cited by 165
Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI
Penz, S., Reininger, A. J., Brandl, R., Goyal, P., Rabie, T., Bernlochner, I., Rother, E., Goetz, C., Engelmann, B., Smethurst, P. A., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2748com · Cited by 165
(2010) · PubMed Central · Cited by 169
Handberg, A., Levin, K., Højlund, K., & Beck-Nielsen, H. (2006) · Circulation · doi:10.1161/circulationaha.106.626135 · Cited by 167
Le, T. T., Langohr, I. M., Locker, M. J., Sturek, M., & Cheng, J.-X. (2007) · Journal of Biomedical Optics · doi:10.1117/1.2795437 · Cited by 166
ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury
Noma, K., Rikitake, Y., Oyama, N., Yan, G., Alcaide, P., Liu, P.-Y., Wang, H., Ahl, D., Sawada, N., Okamoto, R., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci29226 · Cited by 168
Jaffer, F. A., Calfon, M. A., Rosenthal, A., Mallas, G., Razansky, R. N., Mauskapf, A., Weissleder, R., Libby, P., & Ntziachristos, V. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.036 · Cited by 167
Self-citationBaek, J.-H., Kim, B. M., Heo, J. H., Kim, D. J., Nam, H. S., & Kim, Y. D. (2018) · Stroke · doi:10.1161/strokeaha.118.022327 · Cited by 163
The Key Role of DNA Methylation and Histone Acetylation in Epigenetics of Atherosclerosis
Lee, H., Oh, S., Ro, D. H., Yoo, H., & Kwon, Y. (2020) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2020.9.3.419 · Cited by 179
Iacoviello, L., Castelnuovo, A. D., Gattone, M., Pezzini, A., Assanelli, D., Lorenzet, R., Zotto, E. D., Colombo, M., Napoleone, E., Amore, C., et al. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000150039.60906.02 · Cited by 168
Functional Advantages of Porphyromonas gingivalis Vesicles
Ho, M.-H., Chen, C.-H., Goodwin, J. S., Wang, B.-Y., & Xie, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123448 · Cited by 167
Mechanisms involved in the association between peridontal diseases and cardiovascular disease
Teles, R., & Wang, C. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2010.01784.x · Cited by 164
Hergenroeder, G. W., Moore, A. N., McCoy, J. P., Samsel, L., Ward, N. H., Clifton, G. L., & Dash, P. K. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-19 · Cited by 163
Isoda, K., Sawada, S., Ishigami, N., Matsuki, T., Miyazaki, K., Kusuhara, M., Iwakura, Y., & Ohsuzu, F. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000127025.48140.a3 · Cited by 164
Fahed, A. C., & Jang, I. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00542-3 · Cited by 179
Endovascular Injury Induces Rapid Phenotypic Changes in Perivascular Adipose Tissue
Takaoka, M., Suzuki, H., Shioda, S., Sekikawa, K., Saito, Y., Nagai, R., & Sata, M. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207175 · Cited by 165
Kossmann, S., Schwenk, M., Hausding, M., Karbach, S. H., Schmidgen, M. I., Brandt, M., Knorr, M., Hu, H., Kröller-Schön, S., Schönfelder, T., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301437 · Cited by 163
Induction of Oral Tolerance to Oxidized Low-Density Lipoprotein Ameliorates Atherosclerosis
van Puijvelde, G. H. M., Hauer, A. D., de Vos, P., van den Heuvel, R., van Herwijnen, M. J. C., van der Zee, R., van Eden, W., van Berkel, T. J. C., & Kuiper, J. (2006) · Circulation · doi:10.1161/circulationaha.106.615609 · Cited by 164
Inflammation and the Development of Atherosclerosis
Mizuno, Y., Jacob, R. F., & Mason, R. P. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7591 · Cited by 162
Gene Expression Patterns in Peripheral Blood Correlate with the Extent of Coronary Artery Disease
Sinnaeve, P. R., Donahue, M. P., Grass, P., Seo, D., Vonderscher, J., Chibout, S.-D., Kraus, W. E., Sketch, M., Nelson, C., Ginsburg, G. S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007037 · Cited by 167
PPARγ in immunity and inflammation: cell types and diseases
Széles, L., Törőcsik, D., & Nagy, L. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.005 · Cited by 201
Epigenetics in atherosclerosis and inflammation
Wierda, R. J., Geutskens, S. B., Jukema, J. W., Quax, P. H. A., & van den Elsen, P. J. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01022.x · Cited by 160
Norata, G. D., Tibolla, G., Seccomandi, P. M., Poletti, A., & Catapano, A. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1664 · Cited by 163
Krouwer, V. J. D., Hekking, L. H. P., Langelaar-Makkinje, M., Regan-Klapisz, E., & Post, J. (2012) · Vascular Cell · doi:10.1186/2045-824x-4-12 · Cited by 159
Yi, L., Ma, S., & Ren, D. (2017) · Phytochemistry Reviews · doi:10.1007/s11101-017-9497-1 · Cited by 158
Role of p38 MAPK in Atherosclerosis and Aortic Valve Sclerosis
Reustle, A., & Torzewski, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123761 · Cited by 163
PPARδ as a therapeutic target in metabolic disease
Reilly, S. M., & Lee, C.-H. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.040 · Cited by 164
Ronald, J. A., Chen, J. W., Chen, Y., Hamilton, A. M., Rodriguez, E., Reynolds, F., Hegele, R. A., Rogers, K. A., Querol, M., Bogdanov, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.813998 · Cited by 162
SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice
Stein, S., Schäfer, N., Breitenstein, A., Besler, C., Winnik, S., Lohmann, C., Heinrich, K., Brokopp, C. E., Handschin, C., Landmesser, U., et al. (2010) · Aging · doi:10.18632/aging.100162 · Cited by 162
Edry, R., Recea, V., Dikust, Y., & Sessler, D. I. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001130 · Cited by 185
Simonetto, M., Infante, M., Sacco, R. L., Rundek, T., & Della-Morte, D. (2019) · Nutrients · doi:10.3390/nu11102279 · Cited by 153
Identification of Peptides That Antagonize Formyl Peptide Receptor-Like 1-Mediated Signaling
Bae, Y.-S., Lee, H. Y., Jo, E. J., Kim, J. I., Kang, H.-K., Ye, R. D., Kwak, J.-Y., & Ryu, S. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.607 · Cited by 165
Lewis, K. E., Kirk, E. A., McDonald, T. O., Wang, S., Wight, T. N., O’Brien, K. D., & Chait, A. (2004) · Circulation · doi:10.1161/01.cir.0000136819.93989.e1 · Cited by 163
Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease
França, C. N., Izar, M. C. O., Hortêncio, M. N. S., do Amaral, J. B., Ferreira, C. E. S., Tuleta, I. D., & Fonseca, F. A. H. (2017) · Clinical Science · doi:10.1042/cs20170009 · Cited by 160
CHANDRASEKAR, B., MUMMIDI, S., PERLA, R. P., BYSANI, S., DULIN, N. O., LIU, F., & MELBY, P. C. (2003) · Biochemical Journal · doi:10.1042/bj20030207 · Cited by 159
Fatty acid-mediated intracellular iron translocation: A synergistic mechanism of oxidative injury
Yao, D., Shi, W., Gou, Y., Zhou, X., Yee Aw, T., Zhou, Y., & Liu, Z. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.07.015 · Cited by 163
Richard, N., Arnold, S., Hoeller, U., Kilpert, C., Wertz, K., & Schwager, J. (2011) · Planta Medica · doi:10.1055/s-0031-1280022 · Cited by 154
Ni, C.-W., Qiu, H., Rezvan, A., Kwon, K., Nam, D., Son, D. J., Visvader, J. E., & Jo, H. (2010) · Blood · doi:10.1182/blood-2010-04-278192 · Cited by 158
Kong, F., Ye, B., Cao, J., Cai, X., Lin, L., Huang, S., Huang, W., & Huang, Z. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00369 · Cited by 156
Labarrere, C. A., DiCarlo, H. L., Bammerlin, E., Hardin, J. W., Kim, Y. M., Chaemsaithong, P., Haas, D. M., Kassab, G. S., & Romero, R. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.12.029 · Cited by 154
Targeting the Immune System in Atherosclerosis
Zhao, T. X., & Mallat, Z. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.083 · Cited by 158
Cardiovascular organ-on-a-chip platforms for drug discovery and development
Ribas, J., Sadeghi, H., Manbachi, A., Leijten, J., Brinegar, K., Zhang, Y. S., Ferreira, L., & Khademhosseini, A. (2016) · Applied In Vitro Toxicology · doi:10.1089/aivt.2016.0002 · Cited by 161
Role of Complement and Complement Regulatory Proteins in the Complications of Diabetes
Ghosh, P., Sahoo, R., Vaidya, A., Chorev, M., & Halperin, J. A. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1099 · Cited by 154
Tardif, J.-C., L'Allier, P. L., Ibrahim, R., Grégoire, J. C., Nozza, A., Cossette, M., Kouz, S., Lavoie, M.-A., Paquin, J., Brotz, T. M., et al. (2010) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.110.937169 · Cited by 157
A Macrophage‐Targeted Theranostic Nanoparticle for Biomedical Applications
McCarthy, J. R., Jaffer, F. A., & Weissleder, R. (2006) · Small · doi:10.1002/smll.200600139 · Cited by 158
Kalogeropoulos, N., Panagiotakos, D. B., Pitsavos, C., Chrysohoou, C., Rousinou, G., Toutouza, M., & Stefanadis, C. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.01.023 · Cited by 160
Hepatitis C Virus Infection and Increased Risk of Cerebrovascular Disease
Lee, M.-H., Yang, H.-I., Wang, C.-H., Jen, C.-L., Yeh, S.-H., Liu, C.-J., You, S.-L., Chen, W. J., & Chen, C.-J. (2010) · Stroke · doi:10.1161/strokeaha.110.598136 · Cited by 160
Nutrition and human health from a sex–gender perspective
Marino, M., Masella, R., Bulzomi, P., Campesi, I., Malorni, W., & Franconi, F. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.02.001 · Cited by 175
Effects of tea and coffee on cardiovascular disease risk
Bøhn, S. K., Ward, N. C., Hodgson, J. M., & Croft, K. D. (2012) · Food & Function · doi:10.1039/c2fo10288a · Cited by 160
Li, L., Roumeliotis, N., Sawamura, T., & Renier, G. (2004) · Circulation Research · doi:10.1161/01.res.0000147309.54227.42 · Cited by 159
Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis
Aarup, A., Pedersen, T. X., Junker, N., Christoffersen, C., Bartels, E. D., Madsen, M., Nielsen, C. H., & Nielsen, L. B. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.307830 · Cited by 151
Vascular Biomarkers and Surrogates in Cardiovascular Disease
Tardif, J.-C., Heinonen, T., Orloff, D., & Libby, P. (2006) · Circulation · doi:10.1161/circulationaha.105.598987 · Cited by 163
Self-citationBuono, C., Pang, H., Uchida, Y., Libby, P., Sharpe, A. H., & Lichtman, A. H. (2004) · Circulation · doi:10.1161/01.cir.0000127121.16815.f1 · Cited by 155
Self-citationLi, Y., Song, Z. X., Yin, H., Wang, Y. Y., Shu, G., Lu, H. X., Wang, S. K., & Sun, G. J. (2015) · Lipids · doi:10.1007/s11745-015-4091-z · Cited by 177
PET/CT Imaging of Integrin αvβ3 Expression in Human Carotid Atherosclerosis
Beer, A. J., Pelisek, J., Heider, P., Saraste, A., Reeps, C., Metz, S., Seidl, S., Kessler, H., Wester, H.-J., Eckstein, H. H., et al. (2014) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2013.12.003 · Cited by 158
Imaging of Myeloperoxidase in Mice by Using Novel Amplifiable Paramagnetic Substrates
Chen, J. W., Querol Sans, M., Bogdanov, A., & Weissleder, R. (2006) · Radiology · doi:10.1148/radiol.2402050994 · Cited by 153
Risk of coronary heart disease in patients with cancer: A nationwide follow-up study from Sweden
Zöller, B., Ji, J., Sundquist, J., & Sundquist, K. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.09.015 · Cited by 158
Venugopal, S. K., Devaraj, S., & Jialal, I. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62345-0 · Cited by 173
Wung, B., Hsu, M. C., Wu, C., & Hsieh, C. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.052 · Cited by 167
Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role
Venugopal, S. K., Devaraj, S., & Jialal, I. (2005) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200501000-00006 · Cited by 157
Low, A. S. L., Symmons, D. P. M., Lunt, M., Mercer, L. K., Gale, C. P., Watson, K. D., Dixon, W. G., & Hyrich, K. L. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209784 · Cited by 158
The pharmacology of particulate matter air pollution-induced cardiovascular dysfunction
Bai, N., Khazaei, M., van Eeden, S. F., & Laher, I. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.06.005 · Cited by 158
Elkhawad, M., Rudd, J. H. F., Sarov‐Blat, L., Cai, G., Wells, R., Davies, C., Collier, D., Marber, M. S., Choudhury, R. P., Fayad, Z. A., et al. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.02.016 · Cited by 158
Fatigue, Inflammation, and ω-3 and ω-6 Fatty Acid Intake Among Breast Cancer Survivors
Alfano, C. M., Imayama, I., Neuhouser, M. L., Kiecolt-Glaser, J. K., Smith, A. W., Meeske, K., McTiernan, A., Bernstein, L., Baumgartner, K. B., Ulrich, C. M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.4109 · Cited by 152
Photoacoustic imaging of early inflammatory response using gold nanorods
Kim, K., Huang, S.-W., Ashkenazi, S., O’Donnell, M., Agarwal, A., Kotov, N. A., Denny, M. F., & Kaplan, M. J. (2007) · Applied Physics Letters · doi:10.1063/1.2743752 · Cited by 159
Laitinen, I., Saraste, A., Weidl, E., Poethko, T., Weber, A. W., Nekolla, S. G., Leppänen, P., Ylä-Herttuala, S., Hölzlwimmer, G., Walch, A., et al. (2009) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.108.846865 · Cited by 159
Henning, R. J., Bourgeois, M., & Harbison, R. D. (2018) · Cardiovascular Toxicology · doi:10.1007/s12012-018-9462-2 · Cited by 158
The multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities
Sun, Y., Wang, X., Liu, T., Zhu, X., & Pan, X. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00815-5 · Cited by 168
C-reactive protein: From innocent bystander to pivotal mediator of atherosclerosis
Labarrere, C. A., & Zaloga, G. P. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.03.039 · Cited by 175
Marcaccini, A. M., Meschiari, C. A., Sorgi, C. A., Saraiva, M. C. P., de Souza, A. M., Faccioli, L. H., Tanus‐Santos, J. E., Novaes, A. B., & Gerlach, R. F. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.080561 · Cited by 156
Polymeric Nanoparticle PET/MR Imaging Allows Macrophage Detection in Atherosclerotic Plaques
Majmudar, M. D., Yoo, J., Keliher, E. J., Truelove, J. J., Iwamoto, Y., Sena, B., Dutta, P., Borodovsky, A., Fitzgerald, K., Di Carli, M. F., et al. (2013) · Circulation Research · doi:10.1161/circresaha.111.300576 · Cited by 157
Self-citationCorcoran, M. P., Meydani, M., Lichtenstein, A. H., Schaefer, E. J., Dillard, A. C., & Lamon‐Fava, S. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0057 · Cited by 175
Cancer chemoprevention: scientific promise, clinical uncertainty
Sporn, M. B., & Liby, K. T. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0319 · Cited by 176
Xing, D., Oparil, S., Yu, H., Gong, K., Feng, W., Black, J. A., Chen, Y.-F., & Nozell, S. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036890 · Cited by 174
The realm of vitamin K dependent proteins: Shifting from coagulation toward calcification
Willems, B. A. G., Vermeer, C., Reutelingsperger, C. P. M., & Schurgers, L. J. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300743 · Cited by 171
Demyanets, S., Kónya, V., Kastl, S., Kaun, C., Rauscher, S., Niessner, A., Pentz, R., Pfaffenberger, S., Rychli, K., Lemberger, C. E., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.231431 · Cited by 156
Zöller, B., Li, X., Sundquist, J., & Sundquist, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033442 · Cited by 156
Turner, A. W., Hu, S. S., Mosquera, J. V., Ma, W. F., Hodonsky, C. J., Wong, D., Auguste, G., Song, Y., Sol-Church, K., Farber, E., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01069-0 · Cited by 156
Innate Immune Signaling and Porphyromonas gingivalis-accelerated Atherosclerosis
Gibson, F. C., Yumoto, H., Takahashi, Y., Chou, H.-H., & Genco, C. A. (2006) · Journal of Dental Research · doi:10.1177/154405910608500202 · Cited by 155
Pathogenesis of Atherosclerosis
Crowther, M. A. (2005) · Hematology · doi:10.1182/asheducation-2005.1.436 · Cited by 156
Sphingomyelin Synthase 2 Deficiency Attenuates NFκB Activation
Hailemariam, T. K., Huan, C., Liu, J., Li, Z., Roman, C., Kalbfeisch, M., Bui, H. H., Peake, D. A., Kuo, M.-S., Cao, G., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.168682 · Cited by 153
Atherosclerotic Plaque Rupture: Local or Systemic Process?
Lutgens, E., van Suylen, R. J., Faber, B., Gijbels, M. J., Eurlings, P. M. H., Bijnens, A. P., Cleutjens, K. B. J. M., Heeneman, S., & Daemen, M. J. A. P. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000097783.01596.e2 · Cited by 179
Periodontal therapy and cardiovascular risk
Orlandi, M., Graziani, F., & D'Aiuto, F. (2020) · Periodontology 2000 · doi:10.1111/prd.12299 · Cited by 155
Liao, B., Hsieh, C., Liu, Y., Tzeng, T.-T., Sun, Y.-W., & Wung, B. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.01.021 · Cited by 165
From vulnerable plaque to atherothrombosis
Thim, T., Hagensen, M. K., Bentzon, J. F., & Falk, E. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01947.x · Cited by 182
Norata, G. D., Marchesi, P., Passamonti, S., Pirillo, A., Violi, F., & Catapano, A. L. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.047 · Cited by 155
Li, F. Y. L., Cheng, K. K. Y., Lam, K. S. L., Vanhoutte, P. M., & Xu, A. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02216.x · Cited by 151
Othman, R. A., & Moghadasian, M. H. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00399.x · Cited by 154
Viehmann, A., Hertel, S., Fuks, K., Eisele, L., Moebus, S., Möhlenkamp, S., Nonnemacher, M., Jakobs, H., Erbel, R., Jöckel, K.-H., et al. (2015) · Occupational and Environmental Medicine · doi:10.1136/oemed-2014-102800 · Cited by 156
Soran, H., Hama, S., Yadav, R., & Durrington, P. N. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328355ca25 · Cited by 137
Sleep and Inflammation: Psychoneuroimmunology in the Context of Cardiovascular Disease
Motivala, S. J. (2011) · Annals of Behavioral Medicine · doi:10.1007/s12160-011-9280-2 · Cited by 151
Pre-eclampsia: Risk factors and causal models
Trogstad, L., Magnus, P. M., & Stoltenberg, C. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2011.01.007 · Cited by 181
Du, Z., Zhao, D., Li, J., Cui, G., Jin, M., Li, Y., Liu, X., Liu, Y., Du, H., Guo, C., et al. (2013) · Cardiovascular Toxicology · doi:10.1007/s12012-013-9198-y · Cited by 156
Circulating endothelial microparticles as a marker of cerebrovascular disease
Jung, K., Chu, K., Lee, S., Park, H., Bahn, J., Kim, D., Kim, J., Kim, M., Kun Lee, S., & Roh, J. (2009) · Annals of Neurology · doi:10.1002/ana.21681 · Cited by 148
Kazama, K., Usui, T., Okada, M., Hara, Y., & Yamawaki, H. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.04.033 · Cited by 168
The Effects of Dipeptidyl Peptidase-4 Inhibition on Microvascular Diabetes Complications
Avogaro, A., & Fadini, G. P. (2014) · Diabetes Care · doi:10.2337/dc14-0865 · Cited by 164
Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy
Kashyap, D., Sharma, A. K., Sak, K., Tuli, H. S., Buttar, H. S., & Bishayee, A. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.12.005 · Cited by 156
Ambient air pollution and acute myocardial infarction
Vermylen, J., Nemmar, A., Nemery, B., & Hoylaerts, M. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01471.x · Cited by 166
Cytokines and cardiovascular disease
Mehra, V. C., Ramgolam, V. S., & Bender, J. R. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405182 · Cited by 175
Macrophage Sphingomyelin Synthase 2 Deficiency Decreases Atherosclerosis in Mice
Liu, J., Huan, C., Chakraborty, M., Zhang, H., Lü, D., Kuo, M., Cao, G., & Jiang, X. (2009) · Circulation Research · doi:10.1161/circresaha.109.194613 · Cited by 153
Metadata
- Authors
- Libby, P.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Libby, Peter
- ORCID
- Libby, Peter
- Venue
- Nature
- Published
- 2002-12
- Volume
- 420
- Issue
- 6917
- Pages
- 868-874
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2066963386
- Cited by
- 8,315
- References
- 51
- Citations by year
- 2026: 274 · 2025: 198 · 2024: 196 · 2023: 174 · 2022: 245 · 2021: 268 · 2020: 301 · 2019: 279 · 2018: 302 · 2017: 355 · 2016: 368 · 2015: 413 · 2014: 421 · 2013: 474 · 2012: 509
- FWCI
- 19.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- atherosclerosis, inflammation, hypercholesterolemia, atherogenesis, dyslipidemia, leukocyte recruitment, inflammatory cytokines, atheroma formation, thrombosis, myocardial infarction, stroke, lipid-lowering therapy, therapeutic target
- MeSH terms
- Animals, Arteriosclerosis, Chemotaxis, Leukocyte, Disease Susceptibility, Humans, Inflammation, Leukocytes, Risk, Tunica Intima
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.